Pharmaceuticals (28) | Management Agreements (28)

Browse by Company

Recent Contracts

Amendment No. 1, dated as of November 20, 2020, to the Shareholders Agreement, dated as of October 17, 2018, by and among, Osmotica Pharmaceuticals plc, ACP Holdco (Offshore),... (Osmotica Pharmaceuticals plc, Filed With SEC on March 30, 2021)
Strategic Advisory Agreement, dated as of December 11, 2020, by and between Sarissa Capital Management LP and Innoviva, Inc (Innoviva, Inc., Filed With SEC on December 14, 2020)
Management and Services Agreement dated June 15, 2020, among the Company and RP Management, LLC (Royalty Pharma plc, Filed With SEC on October 13, 2020)
Amended and Restated Management and Services Agreement dated June 11, 2020, among Royalty Pharma Investments 2019 ICAV and RP Management, LLC (Royalty Pharma plc, Filed With SEC on October 13, 2020)
Management Services Agreement by and among Registrant, GB Sciences Nevada, LLC, GB Sciences Las Vegas, LLC, and AJE Management, LLC dated December 6, 2020 (GB SCIENCES INC, Filed With SEC on August 28, 2020)
Management Agreement (MICROCHANNEL TECHNOLOGIES CORP, Filed With SEC on July 24, 2020)
Management and Services Agreement dated June 15, 2020, among the Company and RP Management, LLC (Royalty Pharma plc, Filed With SEC on June 19, 2020)
Amended and Restated Management and Services Agreement dated June 11, 2020, among Royalty Pharma Investments 2019 ICAV and RP Management, LLC (Royalty Pharma plc, Filed With SEC on June 19, 2020)
Management Services Agreement dated June 19, 2017 with Dr. Phil Ainslie (Lexaria Bioscience Corp., Filed With SEC on June 3, 2020)
Management Services Agreement dated June 1, 2017 with M&E Services Ltd. (Spissinger) (Lexaria Bioscience Corp., Filed With SEC on June 3, 2020)